Zent, O <br/><br/>
Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.  [electronic resource] 

 -  Vaccine  Sep 2003 
 - 3584-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/s0264-410x(03)00421-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Viral--analysis<br/>Chemistry, Pharmaceutical<br/>Child<br/>Child, Preschool<br/>Encephalitis Viruses, Tick-Borne--immunology<br/>Encephalitis, Tick-Borne--immunology<br/>Excipients<br/>Female<br/>Humans<br/>Infant<br/>Male<br/>Single-Blind Method<br/>Viral Vaccines--adverse effects